What does remission mean for Stomach Cancer and how is it monitored

Understanding Remission in Stomach Cancer

What Remission Means

Remission in stomach cancer refers to a state where the cancer is no longer detectable or has significantly decreased. However, it's important to understand that remission has different levels:

Complete Remission means there are no signs of cancer visible on standard imaging tests (CT scans, endoscopy, etc.). However, this doesn't necessarily mean all cancer cells are gone—some may still exist at a microscopic level that standard medical monitoring cannot detect.

Partial Remission means the cancer has shrunk significantly but is still visible on imaging.

The key distinction for stomach cancer monitoring is that absence of visible disease does not always mean absence of disease—a critical concept that changes how doctors approach follow-up care.

---

How Remission is Monitored

Standard Monitoring Approaches

According to medical oncology guidelines, stomach cancer remission is typically monitored through:

1. Imaging Studies - CT scans or endoscopy performed at regular intervals (typically every 3-6 months initially, then annually)
2. Physical Examinations - Your oncologist checks for signs of recurrence
3. Tumor Markers - Blood tests measuring cancer-related proteins (though these have limitations)
4. Symptom Assessment - Monitoring for new symptoms that might suggest recurrence

The Challenge: Microscopic Disease

As discussed in the CancerPatientLab webinar on "Novel Testing to Guide Personalized Cancer Treatment," there's an important limitation to standard monitoring:

"When your cancer gets small enough, medical monitoring can't see it. And unfortunately, if the medical profession can't see it, they can't treat it. So when your cancer recedes to a certain degree, they often will say your cancer is gone. But it's not necessarily gone. It's still there on a microscopic level, it just can't be seen."

This explains why some patients experience recurrence after being told their cancer was in remission—cancer cells were still circulating but undetectable by conventional imaging.

---

Advanced Monitoring: Circulating Tumor Cells (CTCs)

For stomach cancer patients, emerging testing approaches like circulating tumor cell (CTC) testing offer more sensitive monitoring. According to the webinar on personalized cancer treatment:

What CTCs are: Whole cancer cells that are floating in your bloodstream—detectable through a simple blood draw rather than invasive procedures.

Key advantages:

• Non-invasive - Simple blood draw vs. surgical biopsy
• Real-time information - Reflects current cancer status, not old tissue samples
• Detects microscopic disease - Can identify cancer cells before standard imaging shows recurrence
• Ongoing monitoring - Can be done regularly without the limitations of imaging

Remission Levels with CTC Testing:

According to the webinar, remission status is determined by:

1. CTC Count - Generally, fewer than 1-2 circulating tumor cells is considered a very low-risk or remission level
2. Phenotype Markers - These are specific characteristics of the remaining cells, particularly tumor stem cell markers, which are actually MORE important than just the CTC number

The webinar emphasizes: "You have to make sure that the phenotype markers are also negative or very close to negative...That's actually more important because the subpopulation which the ones with the tumor stem cell markers, they're the ones that drive the disease."

---

Monitoring Strategy After Remission

Three-Month Intervals Initially

According to integrative oncology approaches discussed in the webinars, after achieving remission:

• Months 0-3: Active monitoring with imaging or other evaluation
• Decision point: Based on findings, your oncologist determines next steps (continue current approach, modify treatment, or adjust monitoring)
• Ongoing: This 3-month cycle may continue for several cycles

Long-Term Monitoring

Once remission is stable:

• Annual monitoring with imaging and clinical assessment
• Continued vigilance for any changes in gene expression or tumor markers that might indicate early recurrence

---

Questions to Ask Your Oncologist

To better understand YOUR specific remission monitoring plan:

1. "What imaging schedule will we follow to monitor my remission, and how often?"

2. "Are there any blood tests or tumor markers you'll use to monitor for recurrence?"

3. "Would advanced testing like circulating tumor cell testing be appropriate for my situation to detect microscopic disease earlier?"

4. "What symptoms should I report immediately, and what constitutes a concerning change?"

5. "How will we define remission for my specific case, and what does that mean for my long-term treatment plan?"

6. "If my cancer recurs, what treatment options would be available, and how would we approach it differently?"

---

Key Takeaway

Remission in stomach cancer is an important milestone, but it requires ongoing, thoughtful monitoring. Standard imaging is valuable, but understanding that microscopic disease may persist—and discussing advanced monitoring options with your oncologist—can help catch any recurrence as early as possible. The goal is not just to achieve remission, but to maintain it through appropriate surveillance tailored to your individual situation.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.